Login Register Cart 0
Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Quality of Life Interventions in Breast Cancer Survivors: State of the Art in Targeted Rehabilitation Strategies

Author(s): Marco Invernizzi*, Alessandro de Sire*, Konstantinos Venetis, Emanuele Cigna, Stefano Carda, Margherita Borg, Carlo Cisari and Nicola Fusco

Volume 22, Issue 4, 2022

Published on: 09 June, 2021

Page: [801 - 810] Pages: 10

DOI: 10.2174/1871520621666210609095602

Price: $65

conference banner
Abstract

Breast cancer is the most common malignant tumor and the most prevalent cause of mortality in women. Advances in early diagnosis and more effective adjuvant therapies have improved the long-term survival of these patients. Pharmacotherapies and intrinsic tumor-related factors may lead to a wide spectrum of treatment-related disabling complications, such as breast cancer-related lymphedema, axillary web syndrome, persistent pain, bone loss, arthralgia, and fatigue. These conditions have a detrimental impact on the health-related quality of life of survivors. Here, we sought to provide a portrait of the role that rehabilitation plays in breast cancer survivors. Particular emphasis has been put in terms of recovering function, improving independence in activities of daily living, and reducing disability. This complex scenario requires a precision medicine approach to provide more effective decision-making and adequate treatment compliance.

Keywords: Breast cancer, rehabilitation, quality of life, breast cancer-related lymphedema, lymphedema, cancer-related fatigue, fatigue, bone loss, axillary web syndrome, pain.

« Previous
[1]
Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin., 2020, 70(1), 7-30.
[http://dx.doi.org/10.3322/caac.21590] [PMID: 31912902]
[2]
American Cancer Society How common is breast cancer?, Available from:. https://www.cancer.org/cancer/breast- cancer/about/how-common-is-breast-cancer.html
[3]
Berry, D.A.; Cronin, K.A.; Plevritis, S.K.; Fryback, D.G.; Clarke, L.; Zelen, M.; Mandelblatt, J.S.; Yakovlev, A.Y.; Habbema, J.D.; Feuer, E.J. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med., 2005, 353(17), 1784-1792.
[http://dx.doi.org/10.1056/NEJMoa050518] [PMID: 16251534]
[4]
Michelotti, A.; Invernizzi, M.; Lopez, G.; Lorenzini, D.; Nesa, F.; De Sire, A.; Fusco, N. Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management. Breast, 2019, 44, 15-23.
[http://dx.doi.org/10.1016/j.breast.2018.12.009] [PMID: 30580170]
[5]
de Sire, A.; Losco, L.; Cigna, E.; Lippi, L.; Gimigliano, F.; Gennari, A.; Cisari, C.; Chen, H.C.; Fusco, N.; Invernizzi, M. Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: a proof-of-principle study. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(8), 4476-4485.
[http://dx.doi.org/10.26355/eurrev_202004_21030] [PMID: 32373985]
[6]
Invernizzi, M.; Lopez, G.; Michelotti, A.; Venetis, K.; Sajjadi, E.; De Mattos-Arruda, L.; Ghidini, M.; Runza, L.; de Sire, A.; Boldorini, R.; Fusco, N. Integrating biological advances into the clinical management of breast cancer related lymphedema. Front. Oncol., 2020, 10, 422.
[http://dx.doi.org/10.3389/fonc.2020.00422] [PMID: 32300557]
[7]
Wang, K.; Yee, C.; Tam, S.; Drost, L.; Chan, S.; Zaki, P.; Rico, V.; Ariello, K.; Dasios, M.; Lam, H.; DeAngelis, C.; Chow, E. Prevalence of pain in patients with breast cancer post-treatment: a systematic review. Breast, 2018, 42, 113-127.
[http://dx.doi.org/10.1016/j.breast.2018.08.105] [PMID: 30243159]
[8]
Yang, S.; Chu, S.; Gao, Y.; Ai, Q.; Liu, Y.; Li, X.; Chen, N. A narrative review of cancer-related fatigue (crf) and its possible pathogenesis. Cells, 2019, 8(7),E738.
[http://dx.doi.org/10.3390/cells8070738] [PMID: 31323874]
[9]
Brown, J.C.; Huedo-Medina, T.B.; Pescatello, L.S.; Pescatello, S.M.; Ferrer, R.A.; Johnson, B.T. Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol. Biomarkers Prev., 2011, 20(1), 123-133.
[http://dx.doi.org/10.1158/1055-9965.EPI-10-0988] [PMID: 21051654]
[10]
de Sire, A.; Ferrillo, M.; Gennari, A.; Cisari, C.; Pasqua, S.; Foglio Bonda, P.L.; Invernizzi, M.; Migliario, M. Bone health, vitamin D status and oral hygiene screening in breast cancer women before starting osteoporosis treatment: a cross-sectional study. J. Biol. Regul. Homeost. Agents., 2021, 35(1), 397-402.
[http://dx.doi.org/10.23812/20-686-L] [PMID: 33538147]
[11]
Stearns, V.; Chapman, J.A.; Ma, C.X.; Ellis, M.J.; Ingle, J.N.; Pritchard, K.I.; Budd, G.T.; Rabaglio, M.; Sledge, G.W.; Le Maitre, A.; Kundapur, J.; Liedke, P.E.; Shepherd, L.E.; Goss, P.E. Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial. J. Clin. Oncol., 2015, 33(3), 265-271.
[http://dx.doi.org/10.1200/JCO.2014.57.6926] [PMID: 25512454]
[12]
de Sire, A.; Invernizzi, M.; Lippi, L.; Cisari, C.; Özçakar, L.; Franchignoni, F. Blurred lines between axillary web syndrome and Mondor’s disease after breast cancer surgery: a case report. Ann. Phys. Rehabil. Med., 2020, 63(4), 365-367.
[http://dx.doi.org/10.1016/j.rehab.2019.04.007] [PMID: 31121334]
[13]
de Sire, A.; Losco, L.; Cisari, C.; Gennari, A.; Boldorini, R.; Fusco, N.; Cigna, E.; Invernizzi, M. Axillary web syndrome in women after breast cancer surgery referred to an oncological rehabilitation unit: which are the main risk factors? A retrospective case-control study. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(15), 8028-8035.
[http://dx.doi.org/10.26355/eurrev_202008_22486] [PMID: 32767329]
[14]
El Haidari, R.; Abbas, L.A.; Nerich, V.; Anota, A. Factors associated with health-related quality of life in women with breast cancer in the Middle East: a systematic review. Cancers (Basel), 2020, 12(3), 696.
[http://dx.doi.org/10.3390/cancers12030696] [PMID: 32187972]
[15]
Paraskevi, T. Quality of life outcomes in patients with breast cancer. Oncol. Rev., 2012, 6(1),e2.
[http://dx.doi.org/10.4081/oncol.2012.e2] [PMID: 25992204]
[16]
Franco, P.; Iorio, G.C.; Bartoncini, S.; Airoldi, M.; De Sanctis, C.; Castellano, I.; Ricardi, U. De-escalation of breast radiotherapy after conserving surgery in low-risk early breast cancer patients. Med. Oncol., 2018, 35(5), 62.
[http://dx.doi.org/10.1007/s12032-018-1121-8] [PMID: 29616366]
[17]
DiSipio, T.; Rye, S.; Newman, B.; Hayes, S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol., 2013, 14(6), 500-515.
[http://dx.doi.org/10.1016/S1470-2045(13)70076-7] [PMID: 23540561]
[18]
Vicini, F.; Shah, C.; Arthur, D. The increasing role of lymphedema screening, diagnosis and management as part of evidence-based guidelines for breast cancer care. Breast J., 2016, 22(3), 358-359.
[http://dx.doi.org/10.1111/tbj.12586] [PMID: 26929240]
[19]
Sayegh, H.E.; Asdourian, M.S.; Swaroop, M.N.; Brunelle, C.L.; Skolny, M.N.; Salama, L.; Taghian, A.G. Diagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: past, present, and future directions. Curr. Breast Cancer Rep., 2017, 9(2), 111-121.
[http://dx.doi.org/10.1007/s12609-017-0237-8] [PMID: 28894513]
[20]
Lin, Y.; Xu, Y.; Wang, C.; Song, Y.; Huang, X.; Zhang, X.; Cao, X.; Sun, Q. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis. Breast Cancer, 2021, 28(6), 1261-1272.
[http://dx.doi.org/10.1007/s12282-021-01263-8] [PMID: 34106427]
[21]
Iorio, G.C.; Franco, P.; Gallio, E.; Martini, S.; Arcadipane, F.; Bartoncini, S.; Rondi, N.; Giglioli, F.R.; Ala, A.; Airoldi, M.; Donadio, M.; De Sanctis, C.; Castellano, I.; Ricardi, U. Volumetric modulated arc therapy (VMAT) to deliver nodal irradiation in breast cancer patients. Med. Oncol., 2017, 35(1), 1.
[http://dx.doi.org/10.1007/s12032-017-1061-8] [PMID: 29209826]
[22]
Ribuffo, D.; Berna, G.; De Vita, R. Dual-plane retro-pectoral versus pre-pectoral dti breast reconstruction: an Italian multicenter experience. Aesthetic Plast. Surg., 2020, 28
[http://dx.doi.org/10.1007/s00266-020-01892-y] [PMID: 32860077]
[23]
Losco, L.; Cigna, E. Aesthetic refinements in c-v flap: raising a perfect cylinder. Aesthet. Surg. J., 2018, 38(2), NP26-NP28.
[24]
Abass, M.O.; Gismalla, M.D.A.; Alsheikh, A.A.; Elhassan, M.M.A. Axillary lymph node dissection for breast cancer: efficacy and complication in developing countries. J. Glob. Oncol., 2018, 4, 1-8.
[http://dx.doi.org/10.1200/JGO.18.00080] [PMID: 30281378]
[25]
Gillespie, T.C.; Sayegh, H.E.; Brunelle, C.L.; Daniell, K.M.; Taghian, A.G. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg., 2018, 7(4), 379-403.
[http://dx.doi.org/10.21037/gs.2017.11.04] [PMID: 30175055]
[26]
Boyages, J.; Kalfa, S.; Xu, Y.; Koelmeyer, L.; Mackie, H.; Viveros, H.; Taksa, L.; Gollan, P. Worse and worse off: the impact of lymphedema on work and career after breast cancer. Springerplus, 2016, 5, 657.
[http://dx.doi.org/10.1186/s40064-016-2300-8] [PMID: 27330922]
[27]
Meijer, R.S.; Rietman, J.S.; Geertzen, J.H.B.; Bosmans, J.C.; Dijkstra, P.U. Validity and intra- and interobserver reliability of an indirect volume measurements in patients with upper extremity lymphedema. Lymphology, 2004, 37(3), 127-133.
[PMID: 15560108]
[28]
Mayrovitz, H.N.; Sims, N.; Macdonald, J. Assessment of limb volume by manual and automated methods in patients with limb edema or lymphedema. Adv. Skin Wound Care, 2000, 13(6), 272-276.
[PMID: 12669673]
[29]
Cau, N.; Galli, M.; Cimolin, V.; Aranci, M.; Caraceni, A.; Balzarini, A. Comparative study between circumferential method and laser scanner 3D method for the evaluation of arm volume in healthy subjects. J. Vasc. Surg. Venous Lymphat. Disord., 2016, 4(1), 64-72.
[http://dx.doi.org/10.1016/j.jvsv.2015.05.005] [PMID: 26946898]
[30]
Invernizzi, M.; Runza, L.; De Sire, A.; Lippi, L.; Blundo, C.; Gambini, D.; Boldorini, R.; Ferrero, S.; Fusco, N. Integrating augmented reality tools in breast cancer related lymphedema prognostication and diagnosis. J. Vis. Exp., 2020, 6(156)
[http://dx.doi.org/10.3791/60093] [PMID: 32090996]
[31]
Deltombe, T.; Jamart, J.; Recloux, S.; Legrand, C.; Vandenbroeck, N.; Theys, S.; Hanson, P. Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology, 2007, 40(1), 26-34.
[PMID: 17539462]
[32]
Szuba, A.; Cooke, J.P.; Yousuf, S.; Rockson, S.G. Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am. J. Med., 2000, 109(4), 296-300.
[http://dx.doi.org/10.1016/S0002-9343(00)00503-9] [PMID: 10996580]
[33]
Tzani, I.; Tsichlaki, M.; Zerva, E.; Papathanasiou, G.; Dimakakos, E. Physiotherapeutic rehabilitation of lymphedema: state-of-the-art. Lymphology, 2018, 51(1), 1-12.
[PMID: 30248726]
[34]
Olsson Möller, U.; Beck, I.; Rydén, L.; Malmström, M. A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews. BMC Cancer, 2019, 19(1), 472.
[http://dx.doi.org/10.1186/s12885-019-5648-7] [PMID: 31109309]
[35]
Panchik, D.; Masco, S.; Zinnikas, P.; Hillriegel, B.; Lauder, T.; Suttmann, E.; Chinchilli, V.; McBeth, M.; Hermann, W. Effect of exercise on breast cancer-related lymphedema: what the lymphatic surgeon needs to know. J. Reconstr. Microsurg., 2019, 35(1), 37-45.
[http://dx.doi.org/10.1055/s-0038-1660832] [PMID: 29935493]
[36]
Nelson, N.L. Breast cancer-related lymphedema and resistance exercise: a systematic review. J. Strength Cond. Res., 2016, 30(9), 2656-2665.
[http://dx.doi.org/10.1519/JSC.0000000000001355] [PMID: 26840439]
[37]
Rogan, S.; Taeymans, J.; Luginbuehl, H.; Aebi, M.; Mahnig, S.; Gebruers, N. Therapy modalities to reduce lymphoedema in female breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res. Treat., 2016, 159(1), 1-14.
[http://dx.doi.org/10.1007/s10549-016-3919-4] [PMID: 27460637]
[38]
Romero, A.; Torà-Rocamora, I.; Baré, M.; Barata, T.; Domingo, L.; Ferrer, J.; Torà, N.; Comas, M.; Merenciano, C.; Macià, F.; Castells, X.; Sala, M. Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs. BMC Cancer, 2016, 16(1), 735.
[http://dx.doi.org/10.1186/s12885-016-2768-1] [PMID: 27632982]
[39]
Schug, S.A.; Lavand’homme, P.; Barke, A.; Korwisi, B.; Rief, W.; Treede, R.D. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain, 2019, 160(1), 45-52.
[http://dx.doi.org/10.1097/j.pain.0000000000001413] [PMID: 30586070]
[40]
Juhl, A.A.; Christiansen, P.; Damsgaard, T.E. Persistent pain after breast cancer treatment: a questionnaire-based study on the prevalence, associated treatment variables, and pain type. J. Breast Cancer, 2016, 19(4), 447-454.
[http://dx.doi.org/10.4048/jbc.2016.19.4.447] [PMID: 28053634]
[41]
Belfer, I.; Schreiber, K.L.; Shaffer, J.R.; Shnol, H.; Blaney, K.; Morando, A.; Englert, D.; Greco, C.; Brufsky, A.; Ahrendt, G.; Kehlet, H.; Edwards, R.R.; Bovbjerg, D.H. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J. Pain, 2013, 14(10), 1185-1195.
[http://dx.doi.org/10.1016/j.jpain.2013.05.002] [PMID: 23890847]
[42]
Rietman, J.S.; Dijkstra, P.U.; Debreczeni, R.; Geertzen, J.H.B.; Robinson, D.P.H.; De Vries, J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil. Rehabil., 2004, 26(2), 78-84.
[http://dx.doi.org/10.1080/09638280310001629642] [PMID: 14668143]
[43]
Langford, D.J.; Paul, S.M.; West, C.; Levine, J.D.; Hamolsky, D.; Elboim, C.; Schmidt, B.L.; Cooper, B.A.; Abrams, G.; Aouizerat, B.E.; Miaskowski, C. Persistent breast pain following breast cancer surgery is associated with persistent sensory changes, pain interference, and functional impairments. J. Pain, 2014, 15(12), 1227-1237.
[http://dx.doi.org/10.1016/j.jpain.2014.08.014] [PMID: 25439318]
[44]
Haroutiunian, S.; Nikolajsen, L.; Finnerup, N.B.; Jensen, T.S. The neuropathic component in persistent postsurgical pain: a systematic literature review. Pain, 2013, 154(1), 95-102.
[http://dx.doi.org/10.1016/j.pain.2012.09.010] [PMID: 23273105]
[45]
Khan, J.S.; Ladha, K.S.; Abdallah, F.; Clarke, H. Treating persistent pain after breast cancer surgery. Drugs, 2020, 80(1), 23-31.
[http://dx.doi.org/10.1007/s40265-019-01227-5] [PMID: 31784873]
[46]
Woolf, C.J.; Salter, M.W. Neuronal plasticity: increasing the gain in pain. Science, 2000, 288(5472), 1765-1769.
[http://dx.doi.org/10.1126/science.288.5472.1765] [PMID: 10846153]
[47]
Latremoliere, A.; Woolf, C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain, 2009, 10(9), 895-926.
[http://dx.doi.org/10.1016/j.jpain.2009.06.012] [PMID: 19712899]
[48]
Wang, L.; Guyatt, G.H.; Kennedy, S.A.; Romerosa, B.; Kwon, H.Y.; Kaushal, A.; Chang, Y.; Craigie, S.; de Almeida, C.P.B.; Couban, R.J.; Parascandalo, S.R.; Izhar, Z.; Reid, S.; Khan, J.S.; McGillion, M.; Busse, J.W. Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. CMAJ, 2016, 188(14), E352-E361.
[http://dx.doi.org/10.1503/cmaj.151276] [PMID: 27402075]
[49]
van Helmond, N.; Timmerman, H.; van Dasselaar, N.T.; van de Pol, C.C.; Olesen, S.S.; Drewes, A.M.; Vissers, K.; Wilder-Smith, O.H.; Steegers, M.A. High body mass index is a potential risk factor for persistent postoperative pain after breast cancer treatment. Pain Physician, 2017, 20(5), E661-E671.
[PMID: 28727711]
[50]
Waltho, D.; Rockwell, G. Post-breast surgery pain syndrome: establishing a consensus for the definition of post-mastectomy pain syndrome to provide a standardized clinical and research approach - a review of the literature and discussion. Can. J. Surg., 2016, 59(5), 342-350.
[http://dx.doi.org/10.1503/cjs.000716] [PMID: 27668333]
[51]
Paolucci, T.; Bernetti, A.; Bai, A.V.; Segatori, L.; Monti, M.; Maggi, G.; Ippolitoni, G.; Tinelli, L.; Santilli, V.; Paoloni, M.; Agostini, F.; Mangone, M. The sequelae of mastectomy and quadrantectomy with respect to the reaching movement in breast cancer survivors: evidence for an integrated rehabilitation protocol during oncological care. Support. Care Cancer, 2021, 29(2), 899-908.
[http://dx.doi.org/10.1007/s00520-020-05567-x] [PMID: 32529493]
[52]
Paolucci, T.; Bernetti, A.; Bai, A.V. The recovery of reaching movement in breast cancer survivors: two different rehabilitative protocols in comparison. Eur. J. Phys. Rehabil. Med., 2021, 57(1), 137-147.
[http://dx.doi.org/10.23736/S1973-9087.20.06138-9] [PMID: 32406224]
[53]
Smith, H.S.; Wu, S.X. Persistent pain after breast cancer treatment. Ann. Palliat. Med., 2012, 1(3), 182-194.
[http://dx.doi.org/10.3978/j.issn.2224-5820.2012.10.13] [PMID: 25841510]
[54]
Paice, J.A.; Portenoy, R.; Lacchetti, C.; Campbell, T.; Cheville, A.; Citron, M.; Constine, L.S.; Cooper, A.; Glare, P.; Keefe, F.; Koyyalagunta, L.; Levy, M.; Miaskowski, C.; Otis-Green, S.; Sloan, P.; Bruera, E. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice guideline. J. Clin. Oncol., 2016, 34(27), 3325-3345.
[http://dx.doi.org/10.1200/JCO.2016.68.5206] [PMID: 27458286]
[55]
Moryl, N.; Coyle, N.; Essandoh, S.; Glare, P. Chronic pain management in cancer survivors. J. Natl. Compr. Canc. Netw., 2010, 8(9), 1104-1110.
[http://dx.doi.org/10.6004/jnccn.2010.0079] [PMID: 20876547]
[56]
Eija, K.; Tiina, T.; Neuvonen Pertti, J. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain, 1996, 64(2), 293-302.
[http://dx.doi.org/10.1016/0304-3959(95)00138-7] [PMID: 8740607]
[57]
Tasmuth, T.; Härtel, B.; Kalso, E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur. J. Pain, 2002, 6(1), 17-24.
[http://dx.doi.org/10.1053/eujp.2001.0266] [PMID: 11888224]
[58]
Vilholm, O.J.; Cold, S.; Rasmussen, L.; Sindrup, S.H. Effect of levetiracetam on the postmastectomy pain syndrome. Eur. J. Neurol., 2008, 15(8), 851-857.
[http://dx.doi.org/10.1111/j.1468-1331.2008.02206.x] [PMID: 18565107]
[59]
de Miguel-Jimeno, J.M.; Forner-Cordero, I.; Zabalza-Azparren, M.; Matute-Tobias, B. Sindrome de dolor posmastectomia en nuestro medio: caracteristicas, tratamiento y experiencia con gabapentina. Rev. Neurol., 2016, 62(6), 258-266.
[http://dx.doi.org/10.33588/rn.6206.2015464] [PMID: 26961424]
[60]
Stubblefield, M.D.; Keole, N. Upper body pain and functional disorders in patients with breast cancer. PM R, 2014, 6(2), 170-183.
[http://dx.doi.org/10.1016/j.pmrj.2013.08.605] [PMID: 24360839]
[61]
De Groef, A.; Van Kampen, M.; Dieltjens, E.; Christiaens, M.R.; Neven, P.; Geraerts, I.; Devoogdt, N. Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch. Phys. Med. Rehabil., 2015, 96(6), 1140-1153.
[http://dx.doi.org/10.1016/j.apmr.2015.01.006] [PMID: 25595999]
[62]
De Groef, A.; Van Kampen, M.; Vervloesem, N.; Dieltjens, E.; Christiaens, M.R.; Neven, P.; Vos, L.; De Vrieze, T.; Geraerts, I.; Devoogdt, N. Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial. Clin. Rehabil., 2018, 32(4), 451-461.
[http://dx.doi.org/10.1177/0269215517730863] [PMID: 28914087]
[63]
National Comprehensive Cancer Network. Cancer-related fatigue. clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw., 2003, 1(3), 308-331.
[http://dx.doi.org/10.6004/jnccn.2003.0029] [PMID: 19761067]
[64]
Li, J.; Humphreys, K.; Eriksson, M.; Dar, H.; Brandberg, Y.; Hall, P.; Czene, K. Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: a cross-sectional study. Int. J. Cancer, 2016, 139(11), 2415-2425.
[http://dx.doi.org/10.1002/ijc.30370] [PMID: 27486698]
[65]
Fan, H.G.M.; Houédé-Tchen, N.; Yi, Q-L.; Chemerynsky, I.; Downie, F.P.; Sabate, K.; Tannock, I.F. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J. Clin. Oncol., 2005, 23(31), 8025-8032.
[http://dx.doi.org/10.1200/JCO.2005.01.6550] [PMID: 16258100]
[66]
Bower, J.E.; Bak, K.; Berger, A.; Breitbart, W.; Escalante, C.P.; Ganz, P.A.; Schnipper, H.H.; Lacchetti, C.; Ligibel, J.A.; Lyman, G.H.; Ogaily, M.S.; Pirl, W.F.; Jacobsen, P.B. Screening, assessment, and management of fatigue in adult survivors of cancer: an american society of clinical oncology clinical practice guideline adaptation. J. Clin. Oncol., 2014, 32(17), 1840-1850.
[http://dx.doi.org/10.1200/JCO.2013.53.4495] [PMID: 24733803]
[67]
Thong, M.S.Y.; van Noorden, C.J.F.; Steindorf, K.; Arndt, V. Cancer-related fatigue: causes and current treatment options. Curr. Treat. Options Oncol., 2020, 21(2), 17.
[http://dx.doi.org/10.1007/s11864-020-0707-5] [PMID: 32025928]
[68]
Gilliam, L.A.A.; Moylan, J.S.; Callahan, L.A.; Sumandea, M.P.; Reid, M.B. Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy. Muscle Nerve, 2011, 43(1), 94-102.
[http://dx.doi.org/10.1002/mus.21809] [PMID: 21171100]
[69]
Dirks-Naylor, A.J.; Tran, N.T.K.; Yang, S.; Mabolo, R.; Kouzi, S.A. The effects of acute doxorubicin treatment on proteome lysine acetylation status and apical caspases in skeletal muscle of fasted animals. J. Cachexia Sarcopenia Muscle, 2013, 4(3), 239-243.
[http://dx.doi.org/10.1007/s13539-013-0104-z] [PMID: 23529675]
[70]
Mohandas, H.; Jaganathan, S.K.; Mani, M.P.; Ayyar, M.; Rohini Thevi, G.V. Cancer-related fatigue treatment: an overview. J. Cancer Res. Ther., 2017, 13(6), 916-929.
[http://dx.doi.org/10.4103/jcrt.JCRT_50_17] [PMID: 29237952]
[71]
Minton, O.; Stone, P. A systematic review of the scales used for the measurement of Cancer-Related Fatigue (CRF). Ann. Oncol., 2009, 20(1), 17-25.
[http://dx.doi.org/10.1093/annonc/mdn537] [PMID: 18678767]
[72]
Juvet, L.K.; Thune, I.; Elvsaas, I.K.Ø.; Fors, E.A.; Lundgren, S.; Bertheussen, G.; Leivseth, G.; Oldervoll, L.M. The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: a meta-analysis. Breast, 2017, 33, 166-177.
[http://dx.doi.org/10.1016/j.breast.2017.04.003] [PMID: 28415013]
[73]
Escalante, C.P.; Kallen, M.A.; Valdres, R.U.; Morrow, P.K.; Manzullo, E.F. Outcomes of a cancer-related fatigue clinic in a comprehensive cancer center. J. Pain Symptom Manage., 2010, 39(4), 691-701.
[http://dx.doi.org/10.1016/j.jpainsymman.2009.09.010] [PMID: 20226622]
[74]
Wang, R.; Nakshatri, H. Systemic actions of breast cancer facilitate functional limitations. Cancers (Basel), 2020, 12(1),E194.
[http://dx.doi.org/10.3390/cancers12010194] [PMID: 31941005]
[75]
Berger, A.M.; Kuhn, B.R.; Farr, L.A.; Von Essen, S.G.; Chamberlain, J.; Lynch, J.C.; Agrawal, S. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J. Clin. Oncol., 2009, 27(35), 6033-6040.
[http://dx.doi.org/10.1200/JCO.2008.20.8306] [PMID: 19884558]
[76]
Zick, S.M.; Colacino, J.; Cornellier, M.; Khabir, T.; Surnow, K.; Djuric, Z. Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial. Breast Cancer Res. Treat., 2017, 161(2), 299-310.
[http://dx.doi.org/10.1007/s10549-016-4070-y] [PMID: 27913933]
[77]
Invernizzi, M.; de Sire, A.; Lippi, L.; Venetis, K.; Sajjadi, E.; Gimigliano, F.; Gennari, A.; Criscitiello, C.; Cisari, C.; Fusco, N. Impact of rehabilitation on breast cancer related fatigue: a pilot study. Front. Oncol., 2020, 10,556718.
[http://dx.doi.org/10.3389/fonc.2020.556718] [PMID: 33194622]
[78]
Velthuis, M.J.; Agasi-Idenburg, S.C.; Aufdemkampe, G.; Wittink, H.M. The effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of randomised controlled trials. Clin. Oncol. (R. Coll. Radiol.), 2010, 22(3), 208-221.
[http://dx.doi.org/10.1016/j.clon.2009.12.005] [PMID: 20110159]
[79]
Cramp, F.; Byron-Daniel, J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst. Rev., 2012, 11,CD006145.
[http://dx.doi.org/10.1002/14651858.CD006145.pub3] [PMID: 23152233]
[80]
Meneses-Echávez, J.F.; González-Jiménez, E.; Ramírez-Vélez, R. Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis. BMC Cancer, 2015, 15, 77.
[http://dx.doi.org/10.1186/s12885-015-1069-4] [PMID: 25885168]
[81]
Kröz, M.; Reif, M.; Glinz, A.; Berger, B.; Nikolaou, A.; Zerm, R.; Brinkhaus, B.; Girke, M.; Büssing, A.; Gutenbrunner, C. Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design. BMC Cancer, 2017, 17(1), 166.
[http://dx.doi.org/10.1186/s12885-017-3142-7] [PMID: 28253845]
[82]
Steindorf, K.; Schmidt, M.E.; Klassen, O.; Ulrich, C.M.; Oelmann, J.; Habermann, N.; Beckhove, P.; Owen, R.; Debus, J.; Wiskemann, J.; Potthoff, K. Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life. Ann. Oncol., 2014, 25(11), 2237-2243.
[http://dx.doi.org/10.1093/annonc/mdu374] [PMID: 25096607]
[83]
Dong, B.; Xie, C.; Jing, X.; Lin, L.; Tian, L. Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis. Breast Cancer Res. Treat., 2019, 177(1), 5-16.
[http://dx.doi.org/10.1007/s10549-019-05278-w] [PMID: 31127466]
[84]
Larkey, L.K.; Roe, D.J.; Weihs, K.L.; Jahnke, R.; Lopez, A.M.; Rogers, C.E.; Oh, B.; Guillen-Rodriguez, J. Randomized controlled trial of Qigong/Tai Chi Easy on cancer-related fatigue in breast cancer survivors. Ann. Behav. Med., 2015, 49(2), 165-176.
[http://dx.doi.org/10.1007/s12160-014-9645-4] [PMID: 25124456]
[85]
Vannorsdall, T.D.; Straub, E.; Saba, C. Interventions for multidimensional aspects of breast cancer-related fatigue: a meta-analytic review. Support. Care Cancer, 2021, 29(4), 1753-1764.
[http://dx.doi.org/10.1007/s00520-020-05752-y] [PMID: 33089371]
[86]
Gonnelli, S.; Petrioli, R. Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer. Clin. Interv. Aging, 2008, 3(4), 647-657.
[http://dx.doi.org/10.2147/CIA.S3466] [PMID: 19281057]
[87]
Mirza, F.S.A. Management of bone disease in patients undergoing hormonal therapy for breast cancer. Endocrinol. Metab. Clin. North Am., 2011, 40(3), 549-562.
[http://dx.doi.org/10.1016/j.ecl.2011.05.008]
[88]
Cuzick, J.; Sestak, I.; Baum, M.; Buzdar, A.; Howell, A.; Dowsett, M.; Forbes, J.F. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol., 2010, 11(12), 1135-1141.
[http://dx.doi.org/10.1016/S1470-2045(10)70257-6] [PMID: 21087898]
[89]
Rachner, T.D.; Coleman, R.; Hadji, P.; Hofbauer, L.C. Bone health during endocrine therapy for cancer. Lancet Diabetes Endocrinol., 2018, 6(11), 901-910.
[http://dx.doi.org/10.1016/S2213-8587(18)30047-0] [PMID: 29572126]
[90]
Eastell, R.; Adams, J.; Clack, G.; Howell, A.; Cuzick, J.; Mackey, J.; Beckmann, M.W.; Coleman, R.E. Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial. Ann. Oncol., 2011, 22(4), 857-862.
[http://dx.doi.org/10.1093/annonc/mdq541] [PMID: 20929964]
[91]
Rizzoli, R.; Body, J.J.; DeCensi, A.; Reginster, J.Y.; Piscitelli, P.; Brandi, M.L. Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper. Osteoporos. Int., 2012, 23(11), 2567-2576.
[http://dx.doi.org/10.1007/s00198-011-1870-0] [PMID: 22270857]
[92]
Migliaccio, S.; de Sire, A.; Marocco, C. Approach in aromatase inhibitors - induced osteoporosis: results from an italian multicenter observational study. Clin. Cases Miner. Bone Metab., 2018, 15(3), 334-339.
[93]
Shapiro, C.L.; Manola, J.; Leboff, M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J. Clin. Oncol., 2001, 19(14), 3306-3311.
[http://dx.doi.org/10.1200/JCO.2001.19.14.3306] [PMID: 11454877]
[94]
Amir, E.; Seruga, B.; Niraula, S.; Carlsson, L.; Ocaña, A. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J. Natl. Cancer Inst., 2011, 103(17), 1299-1309.
[http://dx.doi.org/10.1093/jnci/djr242] [PMID: 21743022]
[95]
Fukumoto, S.; Soen, S.; Taguchi, T.; Ishikawa, T.; Matsushima, H.; Terauchi, M.; Horie, S.; Yoneda, T.; Sugimoto, T.; Matsumoto, T. Management manual for Cancer Treatment-Induced Bone Loss (CTIBL): position statement of the JSBMR. J. Bone Miner. Metab., 2020, 38(2), 141-144.
[http://dx.doi.org/10.1007/s00774-020-01087-0] [PMID: 32020289]
[96]
Hadji, P.; Ziller, M.; Kieback, D.G.; Dornoff, W.; Tessen, H.W.; Menschik, T.; Kuck, J.; Melchert, F.; Hasenburg, A. Effects of exemestane and tamoxifen on bone health within the tamoxifen exemestane adjuvant multicentre (team) trial: results of a German, 12-month, prospective, randomised substudy. Ann. Oncol., 2009, 20(7), 1203-1209.
[http://dx.doi.org/10.1093/annonc/mdn762] [PMID: 19218306]
[97]
D’Oronzo, S.; Stucci, S.; Tucci, M.; Silvestris, F. Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications. Cancer Treat. Rev., 2015, 41(9), 798-808.
[http://dx.doi.org/10.1016/j.ctrv.2015.09.003] [PMID: 26410578]
[98]
Tran, T.; Bliuc, D.; Pham, H.M.; van Geel, T.; Adachi, J.D.; Berger, C.; van den Bergh, J.; Eisman, J.A.; Geusens, P.; Goltzman, D.; Hanley, D.A.; Josse, R.G.; Kaiser, S.M.; Kovacs, C.S.; Langsetmo, L.; Prior, J.C.; Nguyen, T.V.; Center, J.R. A risk assessment tool for predicting fragility fractures and mortality in the elderly. J. Bone Miner. Res., 2020, 35(10), 1923-1934.
[http://dx.doi.org/10.1002/jbmr.4100] [PMID: 32460361]
[99]
Watts, N.B. The fracture risk assessment tool (FRAX®): applications in clinical practice. J. Womens Health (Larchmt.), 2011, 20(4), 525-531.
[http://dx.doi.org/10.1089/jwh.2010.2294] [PMID: 21438699]
[100]
Demark-Wahnefried, W.; Aziz, N.M.; Rowland, J.H.; Pinto, B.M. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J. Clin. Oncol., 2005, 23(24), 5814-5830.
[http://dx.doi.org/10.1200/JCO.2005.01.230] [PMID: 16043830]
[101]
Niravath, P. Aromatase inhibitor-induced arthralgia: a review. Ann. Oncol., 2013, 24(6), 1443-1449.
[http://dx.doi.org/10.1093/annonc/mdt037] [PMID: 23471104]
[102]
Boonstra, A.; van Zadelhoff, J.; Timmer-Bonte, A.; Ottevanger, P.B.; Beurskens, C.H.; van Laarhoven, H.W. Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers. Cancer Nurs., 2013, 36(1), 52-59.
[http://dx.doi.org/10.1097/NCC.0b013e31824a7e18] [PMID: 22495502]
[103]
Coates, A.S.; Keshaviah, A.; Thürlimann, B.; Mouridsen, H.; Mauriac, L.; Forbes, J.F.; Paridaens, R.; Castiglione-Gertsch, M.; Gelber, R.D.; Colleoni, M.; Láng, I.; Del Mastro, L.; Smith, I.; Chirgwin, J.; Nogaret, J.M.; Pienkowski, T.; Wardley, A.; Jakobsen, E.H.; Price, K.N.; Goldhirsch, A. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J. Clin. Oncol., 2007, 25(5), 486-492.
[http://dx.doi.org/10.1200/JCO.2006.08.8617] [PMID: 17200148]
[104]
Beckwée, D.; Leysen, L.; Meuwis, K.; Adriaenssens, N. Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis. Support. Care Cancer, 2017, 25(5), 1673-1686.
[http://dx.doi.org/10.1007/s00520-017-3613-z] [PMID: 28204994]
[105]
Gaillard, S.; Stearns, V. Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. Breast Cancer Res., 2011, 13(2), 205.
[http://dx.doi.org/10.1186/bcr2818] [PMID: 21457526]
[106]
Martín-Millán, M.; Castañeda, S. Estrogens, osteoarthritis and inflammation. Joint Bone Spine, 2013, 80(4), 368-373.
[http://dx.doi.org/10.1016/j.jbspin.2012.11.008] [PMID: 23352515]
[107]
Zhang, Y.; McAlindon, T.E.; Hannan, M.T.; Chaisson, C.E.; Klein, R.; Wilson, P.W.; Felson, D.T. Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the framingham study. Arthritis Rheum., 1998, 41(10), 1867-1873.
[http://dx.doi.org/10.1002/1529-0131(199810)41:10<1867:AID-ART20>3.0.CO;2-W] [PMID: 9778229]
[108]
Vural, P.; Akgul, C.; Canbaz, M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol. Res., 2006, 54(4), 298-302.
[http://dx.doi.org/10.1016/j.phrs.2006.06.006] [PMID: 16879975]
[109]
Crew, K.D.; Greenlee, H.; Capodice, J.; Raptis, G.; Brafman, L.; Fuentes, D.; Sierra, A.; Hershman, D.L. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J. Clin. Oncol., 2007, 25(25), 3877-3883.
[http://dx.doi.org/10.1200/JCO.2007.10.7573] [PMID: 17761973]
[110]
Roberts, K.; Rickett, K.; Greer, R.; Woodward, N. Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: a systematic review and meta-analysis. Crit. Rev. Oncol. Hematol., 2017, 111, 66-80.
[http://dx.doi.org/10.1016/j.critrevonc.2017.01.010] [PMID: 28259297]
[111]
Irwin, M.L.; Cartmel, B.; Gross, C.P.; Ercolano, E.; Li, F.; Yao, X.; Fiellin, M.; Capozza, S.; Rothbard, M.; Zhou, Y.; Harrigan, M.; Sanft, T.; Schmitz, K.; Neogi, T.; Hershman, D.; Ligibel, J. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J. Clin. Oncol., 2015, 33(10), 1104-1111.
[http://dx.doi.org/10.1200/JCO.2014.57.1547] [PMID: 25452437]
[112]
Anand, K.; Niravath, P. Acupuncture and vitamin D for the management of aromatase inhibitor-induced arthralgia. Curr. Oncol. Rep., 2019, 21(6), 51.
[http://dx.doi.org/10.1007/s11912-019-0795-1] [PMID: 30997616]
[113]
Cheville, A.L.; Tchou, J. Barriers to rehabilitation following surgery for primary breast cancer. J. Surg. Oncol., 2007, 95(5), 409-418.
[http://dx.doi.org/10.1002/jso.20782] [PMID: 17457830]
[114]
Moskovitz, A.H.; Anderson, B.O.; Yeung, R.S.; Byrd, D.R.; Lawton, T.J.; Moe, R.E. Axillary web syndrome after axillary dissection. Am. J. Surg., 2001, 181(5), 434-439.
[http://dx.doi.org/10.1016/S0002-9610(01)00602-X] [PMID: 11448437]
[115]
Yeung, W.M.; McPhail, S.M.; Kuys, S.S. A systematic review of Axillary Web Syndrome (AWS). J. Cancer Surviv., 2015, 9(4), 576-598.
[http://dx.doi.org/10.1007/s11764-015-0435-1] [PMID: 25682072]
[116]
Koehler, L.A.; Haddad, T.C.; Hunter, D.W.; Tuttle, T.M. Axillary web syndrome following breast cancer surgery: symptoms, complications, and management strategies. Breast Cancer (Dove Med. Press), 2018, 11, 13-19.
[http://dx.doi.org/10.2147/BCTT.S146635] [PMID: 30588087]
[117]
Dinas, K.; Kalder, M.; Zepiridis, L.; Mavromatidis, G.; Pratilas, G. Axillary web syndrome: incidence, pathogenesis, and management. Curr. Probl. Cancer, 2019, 43(6),100470.
[http://dx.doi.org/10.1016/j.currproblcancer.2019.02.002] [PMID: 30898366]
[118]
Leidenius, M.; Leppänen, E.; Krogerus, L.; von Smitten, K. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am. J. Surg., 2003, 185(2), 127-130.
[http://dx.doi.org/10.1016/S0002-9610(02)01214-X] [PMID: 12559441]
[119]
Luz, C.M.D.; Deitos, J.; Siqueira, T.C.; Palú, M.; Heck, A.P.F. Management of axillary web syndrome after breast cancer: evidence-based practice. Rev. Bras. Ginecol. Obstet., 2017, 39(11), 632-639.
[http://dx.doi.org/10.1055/s-0037-1604181] [PMID: 28701024]
[120]
Reedijk, M.; Boerner, S.; Ghazarian, D.; McCready, D. A case of axillary web syndrome with subcutaneous nodules following axillary surgery. Breast, 2006, 15(3), 411-413.
[http://dx.doi.org/10.1016/j.breast.2005.09.005] [PMID: 16257525]
[121]
Cho, Y.; Do, J.; Jung, S.; Kwon, O.; Jeon, J.Y. Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection. Support. Care Cancer, 2016, 24(5), 2047-2057.
[http://dx.doi.org/10.1007/s00520-015-3005-1] [PMID: 26542271]
[122]
Piper, M.; Guajardo, I.; Denkler, K.; Sbitany, H. Axillary web syndrome: Current understanding and new directions for treatment. Ann. Plast. Surg., 2016, 76(Suppl. 3), S227-S231.
[http://dx.doi.org/10.1097/SAP.0000000000000767] [PMID: 27070684]
[123]
Harris, S.R. Axillary web syndrome in breast cancer: a prevalent but under-recognized postoperative complication. Breast Care (Basel), 2018, 13(2), 132-135.
[http://dx.doi.org/10.1159/000485023] [PMID: 29887791]
[124]
Invernizzi, M.; Kim, J.; Fusco, N. Editorial: quality of life in breast cancer patients and survivors. Front. Oncol., 2020, 10,620574.
[http://dx.doi.org/10.3389/fonc.2020.620574] [PMID: 33312961]

Rights & Permissions Print Cite
Article Metrics
124
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy